144 related articles for article (PubMed ID: 12034248)
1. Campath-1H in intestinal and multivisceral transplantation: preliminary data.
Tzakis AG; Kato T; Nishida S; Levi D; Madariaga J; De Faria W; Nery J; Neff G; Kirk AD; Ruiz P
Transplant Proc; 2002 May; 34(3):937. PubMed ID: 12034248
[No Abstract] [Full Text] [Related]
2. Daclizumab and alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: rejection and infection rates in 40 recipients during the early postoperative period.
Zanfi C; Lauro A; Cescon M; Dazzi A; Ercolani G; Grazi GL; Zanello M; Vivarelli M; Del Gaudio M; Ravaioli M; Cucchetti A; Vetrone G; Tuci F; Di Gioia P; Lazzarotto T; D'Errico A; Bagni A; Faenza S; Siniscalchi A; Pironi L; Pinna AD
Transplant Proc; 2010; 42(1):35-8. PubMed ID: 20172276
[TBL] [Abstract][Full Text] [Related]
3. Preliminary experience with campath 1H (C1H) in intestinal and liver transplantation.
Tzakis AG; Kato T; Nishida S; Levi DM; Madariaga JR; Nery JR; Mittal N; Regev A; Cantwell P; Gyamfi A; Weppler D; Miller J; Tryphonopoulos P; Ruiz P
Transplantation; 2003 Apr; 75(8):1227-31. PubMed ID: 12717207
[TBL] [Abstract][Full Text] [Related]
4. Daclizumab and alemtuzumab as induction agents in adult intestinal and multivisceral transplantation: A comparison of two different regimens on 29 recipients during the early post-operative period.
Lauro A; Amaduzzi A; Dazzi A; Ercolani G; Zanfi C; Golfieri L; Grazi GL; Vivarelli M; Cescon M; Varotti G; Del Gaudio M; Ravaioli M; Siniscalchi A; Faenza S; D'Errico A; Di Simone M; Pironi L; Pinna AD
Dig Liver Dis; 2007 Mar; 39(3):253-6. PubMed ID: 17275428
[TBL] [Abstract][Full Text] [Related]
5. Campath-1H immunosuppressive therapy reduces incidence and intensity of acute rejection in intestinal and multivisceral transplantation.
Garcia M; Weppler D; Mittal N; Nishida S; Kato T; Tzakis A; Ruiz P
Transplant Proc; 2004 Mar; 36(2):323-4. PubMed ID: 15050146
[TBL] [Abstract][Full Text] [Related]
6. Induction therapy for adult small bowel transplant with Campath-1H.
Nishida S; Levi D; Kato T; Madariaga J; Nery J; Tzakis A
Transplant Proc; 2002 Aug; 34(5):1889-91. PubMed ID: 12176616
[No Abstract] [Full Text] [Related]
7. Intestinal transplantation with alemtuzumab (Campath-1H) induction for adult patients.
Nishida S; Levi DM; Moon JI; Madariaga JR; Kato T; Selvaggi G; Tryphonopoulos P; DeFaria W; Santiago S; Gaynor J; Weppler D; Martinez E; Ruiz P; Tzakis AG
Transplant Proc; 2006; 38(6):1747-9. PubMed ID: 16908270
[TBL] [Abstract][Full Text] [Related]
8. The impact of Campath 1H induction in adult liver allotransplantation.
Tryphonopoulos P; Madariaga JR; Kato T; Nishida S; Levi DM; Moon J; Selvaggi G; De Faria W; Regev A; Bejarano P; Khaled A; Safdar K; Esquenazi V; Weppler D; Yoshida H; Ruiz P; Miller J; Tzakis AG
Transplant Proc; 2005 Mar; 37(2):1203-4. PubMed ID: 15848669
[TBL] [Abstract][Full Text] [Related]
9. Intestinal transplantation: advances in immunosuppression and surgical techniques.
Tzakis AG; Tryphonopoulos P; Kato T; Nishida S; Levi DM; Nery JR; Madariaga J; De Faria W; Mittal N; Thompson JF; Ruiz P
Transplant Proc; 2003 Aug; 35(5):1925-6. PubMed ID: 12962850
[TBL] [Abstract][Full Text] [Related]
10. Results of intestinal and multivisceral transplantation in adult patients: Italian experience.
Lauro A; Dazzi A; Ercolani G; Cescon M; D'Errico A; Di Simone M; Grazi GL; Vivarelli M; Varotti G; De Ruvo N; Masetti M; Cautero N; Di Benedetto F; Siniscalchi A; Begliomini B; Lazzarotto T; Faenza S; Pironi L; Pinna AD
Transplant Proc; 2006; 38(6):1696-8. PubMed ID: 16908252
[TBL] [Abstract][Full Text] [Related]
11. Alemtuzumab (Campath-1H) combined with tacrolimus in intestinal and multivisceral transplantation.
Tzakis AG; Kato T; Nishida S; Levi DM; Tryphonopoulos P; Madariaga JR; De Faria W; Nery JR; Regev A; Vianna R; Miller J; Esquenazi V; Weppler D; Ruiz P
Transplantation; 2003 May; 75(9):1512-7. PubMed ID: 12792506
[TBL] [Abstract][Full Text] [Related]
12. [Preliminary experience with Campath 1H induction combined with low-dose monotherapy of tacrolimus in small bowel transplantation].
Li YX; Li N; Ni XD; Li YS; Li M; Shen J; Li JS
Zhonghua Wai Ke Za Zhi; 2009 Jun; 47(11):810-3. PubMed ID: 19961008
[TBL] [Abstract][Full Text] [Related]
13. Evolution of the immunosuppressive strategies for the intestinal and multivisceral recipients with special reference to allograft immunity and achievement of partial tolerance.
Abu-Elmagd KM; Costa G; Bond GJ; Wu T; Murase N; Zeevi A; Simmons R; Soltys K; Sindhi R; Stein W; Demetris A; Mazariegos G
Transpl Int; 2009 Jan; 22(1):96-109. PubMed ID: 18954362
[TBL] [Abstract][Full Text] [Related]
14. The long-term efficacy of multivisceral transplantation.
Madariaga JR; Reyes J; Mazariegos G; Fung JJ; Starzl TE; Abu-Elmagd K
Transplant Proc; 2000 Sep; 32(6):1219-20. PubMed ID: 10995918
[No Abstract] [Full Text] [Related]
15. Recipient memory-like lymphocytes remain unresponsive to graft antigens after CAMPATH-1H induction with reduced maintenance immunosuppression.
Trzonkowski P; Zilvetti M; Friend P; Wood KJ
Transplantation; 2006 Nov; 82(10):1342-51. PubMed ID: 17130784
[TBL] [Abstract][Full Text] [Related]
16. Prope tolerance with alemtuzumab.
Calne RY
Liver Transpl; 2005 Mar; 11(3):361-3. PubMed ID: 15719401
[No Abstract] [Full Text] [Related]
17. Therapeutic use of an extemporaneously prepared oral suspension of tacrolimus in pediatric patients.
McGhee B; McCombs JR; Boyle G; Webber SA; Reyes JR
Transplantation; 1997 Sep; 64(6):941-2. PubMed ID: 9326429
[No Abstract] [Full Text] [Related]
18. Subcutaneous administration of alemtuzumab in simultaneous pancreas-kidney transplantation.
Clatworthy MR; Sivaprakasam R; Butler AJ; Watson CJ
Transplantation; 2007 Dec; 84(12):1563-7. PubMed ID: 18165765
[TBL] [Abstract][Full Text] [Related]
19. Living-related donor renal transplantation in HIV+ recipients using alemtuzumab preconditioning and steroid-free tacrolimus monotherapy: a single center preliminary experience.
Tan HP; Kaczorowski DJ; Basu A; Khan A; McCauley J; Marcos A; Fung JJ; Starzl TE; Shapiro R
Transplantation; 2004 Dec; 78(11):1683-8. PubMed ID: 15591960
[TBL] [Abstract][Full Text] [Related]
20. Alemtuzumab (Campath 1H) induction with tacrolimus monotherapy is safe for high immunological risk renal transplantation.
Thomas PG; Woodside KJ; Lappin JA; Vaidya S; Rajaraman S; Gugliuzza KK
Transplantation; 2007 Jun; 83(11):1509-12. PubMed ID: 17565326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
